Can the British American Tobacco dividend keep growing?

A market update from the smoking giant has our writer wondering about where the British American Tobacco dividend may go next and what it means for his portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One of my biggest holdings is in British American Tobacco (LSE: BATS). The giant behind cigarette brands such as Pall Mall and Dunhill is a cash generation machine.

That has been good news for the British American Tobacco dividend over the past few years. But do the future prospects make it worthwhile for me to hang onto the shares? After all, cigarette sales are steadily declining annually in many markets.

British American Tobacco continues to grow

Perhaps, surprisingly, the company actually has a growing business. In its interim results released today, British American said that revenues increased 5.7% in the first six months of the year, including some benefit from exchange rates.

That does not mean volumes were up. In fact, the key US market saw volumes of combustible products such as cigarettes decline 13.4% in the period. That is a big drop, even allowing for a strong comparative period last year.

But the addictive nature of tobacco means the company can push prices up and many smokers will still buy their favourite brands. So although the overall combustible business showed 0.6% revenue growth in the period, that was due to the effects of price and the mix of what products were sold. Although revenues increased slightly, volumes fell.

However, the performance illustrates the company’s pricing power. It has the ability to keep raising  prices to try and offset declining volumes. On top of that, some growth came from the non-cigarette product range. British American has been focussing on this. Non-cigarette sales jumped 45%.

What about the dividend?

The results were weaker than I would have liked and the sharp fall in US cigarette volumes is a concerning trend. That could hurt revenues and profits if it continues.

But the company maintained its full-year guidance, including a commitment to dividend growth in sterling terms. The British American Tobacco dividend has grown annually for more than two decades. Last year’s growth was 2.5%. The company is also buying back £2bn of its shares. As part of that programme it spent £1.3bn in the first half.

Dividends are never guaranteed. But the company’s strong free cashflows (£2.3bn in the first half) and progressive dividend strategy give me a fair degree of confidence it will grow the dividend again when it announces its final results for the year.

Although net debt of £41bn was a bit lower than at the same point last year, it was higher than six months ago. I see the need to service that debt as a long-term risk to the dividend.

My move

I will continue to hold my shares and happily collect the next quarterly British American Tobacco dividend on 17 August.

Over the past year, the shares are up 25%. That means that the dividend yield has fallen. But the yield is still 6.3%. I regard that as attractive.

The highly cash generative nature of the business, which enables a generous dividend, is appealing. I also think that through a combination of raising prices, growing the non-cigarette business and making acquisitions, the firm can continue to grow even as cigarette volumes in developed markets decline.

I would happily add more of these shares to my portfolio.

Christopher Ruane owns shares in British American Tobacco. The Motley Fool UK has recommended British American Tobacco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Down 39.5%, this UK stock offers a 6.52% dividend yield for investors!

This unloved food processing business is now offering a chunky 6%+ dividend yield as management seeks to fix recent challenges…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

64% under ‘fair value’ with 36% annual forecast earnings growth! 1 overlooked FTSE 250 gem to buy today?

This overlooked FTSE 250 retailer has quietly rebuilt itself into a profit machine, but the market hasn’t noticed. The valuation…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

How £500 unlocks £34.05 passive income with this 6.81% yielding stock

Zaven Boyrazian explains the draw of this income stock, with its high yield and cash-generative traits that could make it…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

I’m targeting £9,089 a year in dividends from £20,000 in this powerhouse FTSE income share

This heavyweight FTSE income share offers a rising payout and a valuation that looks primed for a catch‑up, giving investors…

Read more »

Queen Street, one of Cardiff's main shopping streets, busy with Saturday shoppers.
Investing Articles

Is now a once-in-a-decade opportunity to buy Vistry shares?

Vistry shares just got even cheaper! Could now be one of those rare opportunites to pick up the shares at…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

UK investors are piling into GSK! Should I buy this FTSE 100 stock?

Zaven Boyrazian explains why retail investors are rushing to buy this FTSE 100 pharmaceutical giant and explores whether now's the…

Read more »

piggy bank, searching with binoculars
Investing Articles

Around £5 now, here’s why this overlooked FTSE 100 heavyweight seems a bargain to me anywhere below £10.92

This FTSE 100 commodities giant is powering into a major revival, yet the market still prices it like a laggard,…

Read more »

Stack of one pound coins falling over
Investing Articles

If a stock market crash is coming, this is the FTSE shares I want to buy

High-ranking economists are forecasting tough times ahead for the UK stock market. In one way, Paul Summers is hoping they're…

Read more »